Share-based Payment Arrangement, Expense of IVERIC bio, Inc. from 31 Dec 2011 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IVERIC bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2011 to 31 Mar 2023.
  • IVERIC bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2023 was $11,899,000, a 121% increase year-over-year.
  • IVERIC bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2023 was $33,189,000, a 131% increase year-over-year.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26,676,000, a 137% increase from 2021.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11,245,000, a 35% increase from 2020.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $8,323,000, a 9.3% decline from 2019.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IVERIC bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $33,189,000 $11,899,000 +$6,513,000 +121% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $26,676,000 $8,346,000 +$4,098,000 +96% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
Q3 2022 $22,578,000 $6,556,000 +$3,930,000 +150% 01 Jul 2022 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $18,648,000 $6,388,000 +$4,309,000 +207% 01 Apr 2022 30 Jun 2022 10-Q 26 Jul 2022 2022 Q2
Q1 2022 $14,339,000 $5,386,000 +$3,094,000 +135% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $11,245,000 $4,248,000 +$1,969,000 +86% 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $9,276,000 $2,626,000 +$779,000 +42% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $8,497,000 $2,079,000 +$206,000 +11% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022 2022 Q2
Q1 2021 $8,291,000 $2,292,000 -$32,000 -1.4% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $8,323,000 $2,279,000 -$98,000 -4.1% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $8,421,000 $1,847,000 -$279,000 -13% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $8,700,000 $1,873,000 -$334,000 -15% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $9,034,000 $2,324,000 -$146,000 -5.9% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $9,180,000 $2,377,000 -$347,000 -13% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $9,527,000 $2,126,000 -$478,000 -18% 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020 2020 Q3
Q2 2019 $10,005,000 $2,207,000 -$455,000 -17% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $10,460,000 $2,470,000 -$612,000 -20% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $11,072,000 $2,724,000 -$984,000 -27% 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2021 2020 FY
Q3 2018 $12,056,000 $2,604,000 -$807,000 -24% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $12,863,000 $2,662,000 -$2,326,000 -47% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $15,189,000 $3,082,000 -$2,982,000 -49% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $18,171,000 $3,708,000 -$3,063,000 -45% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q3 2017 $21,234,000 $3,411,000 -$4,837,000 -59% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $26,071,000 $4,988,000 -$3,321,000 -40% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2
Q1 2017 $29,392,000 $6,064,000 -$2,268,000 -27% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $31,660,000 $6,771,000 +$485,000 +7.7% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $31,175,000 $8,248,000 +$1,207,000 +17% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $29,968,000 $8,309,000 +$1,930,000 +30% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $28,038,000 $8,332,000 +$3,278,000 +65% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $24,760,000 $6,286,000 +$2,738,000 +77% 01 Oct 2015 31 Dec 2015 10-K 05 Mar 2018 2017 FY
Q3 2015 $22,022,000 $7,041,000 +$3,461,000 +97% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 $18,561,000 $6,379,000 +$3,196,000 +100% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $15,365,000 $5,054,000 +$2,325,000 +85% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $13,040,000 $3,548,000 +$2,284,000 +181% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
Q3 2014 $10,756,000 $3,580,000 +$2,433,000 +212% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $8,323,000 $3,183,000 +$2,831,000 +804% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $5,492,000 $2,729,000 +$2,621,000 +2427% 01 Jan 2014 31 Mar 2014 10-Q/A 28 Jul 2015 2015 Q1
Q4 2013 $2,871,000 $1,264,000 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $1,147,000 +$997,000 +665% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $352,000 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2014 Q2
Q1 2013 $108,000 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
Q3 2012 $150,000 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3

IVERIC bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $26,676,000 +$15,431,000 +137% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 $11,245,000 +$2,922,000 +35% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 $8,323,000 -$857,000 -9.3% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $9,180,000 -$1,892,000 -17% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $11,072,000 -$7,099,000 -39% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2021 2020 FY
2017 $18,171,000 -$13,489,000 -43% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $31,660,000 +$6,900,000 +28% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $24,760,000 +$11,720,000 +90% 01 Jan 2015 31 Dec 2015 10-K 05 Mar 2018 2017 FY
2014 $13,040,000 +$10,169,000 +354% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $2,871,000 +$2,231,000 +349% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $640,000 +$392,000 +158% 01 Jan 2012 31 Dec 2012 10-K/A 28 Jul 2015 2014 FY
2011 $248,000 01 Jan 2011 31 Dec 2011 10-K 11 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.